Online Surveys to Assess the Perception and Performance of Imaging and Associated Aspects

Perception of Imaging Clinical Trial

Official title:

Online Surveys to Assess the Perception and Performance of Imaging Associated Aspects

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT03494335
• Other study ID #: RP0320_S02/2018E0141
• Status: Withdrawn
• Start date: August 30, 2022
• Est. completion date: December 31, 2024

Study information

• Verified date: January 2024
• Source: University of Cincinnati
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

In this exploratory study, the researchers would like to investigate the background, perception, current use practices, potential unmet needs and/or challenges in regard to imaging procedures, imaging technology, or any other aspect related to the broader field of imaging.

Description:

The researchers plan to include volunteer participants to complete these surveys. The goal of these exploratory efforts will be to increase the currently very limited information available in the topics of interest stated above, and the findings, even if only from limited group of respondents, will help guide research development, prepare for design of clinical trials, guide special interest groups, and serve as role data for appropriate scientific publications.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: December 31, 2024
• Est. primary completion date: December 31, 2024
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Male and female participants who have access to the online survey tool and can read and write in English

Exclusion Criteria:

• None, as this is voluntary

Related Conditions & MeSH terms

• Perception of Imaging

Intervention

Other:
• Online surveys
The investigators are recruiting health care providers for these surveys that are involved in or use imaging.

Locations

Country	Name	City	State
United States	Martha Morehouse Medical Plaza	Columbus	Ohio

Sponsors (1)

Lead Sponsor	Collaborator
University of Cincinnati

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Perception of PET/CT imaging agent Y-90	To evaluate participants' perceptions of Y-90 using a likert scale on an online survey	through study completion, on average 2-5 years
Primary	Perception of PET/CT imaging agent NaF	To evaluate participants' perceptions of NaF using a likert scale on an online survey	through study completion, on average 2-5 years
Primary	Perception of MRI contrast agents	To evaluate participants' perceptions of MR contrast agents using a likert scale	through study completion, on average 2-5 years